Associate Medical Director, Remote Oncology Development

Sumitomo Pharma; Hartford (CT); Remote; USD 226,000 - 282,000; Full time

Job summary

Sumitomo Pharma Co., Ltd. is seeking an Associate Medical Director, Clinical Development – Oncology to lead the design, execution, and management of oncology studies. You will foster investigator relationships and guide cross‑functional teams in safety and efficacy assessments across global programs.

The role emphasizes hematologic malignancies and collaboration with regulatory, medical affairs, and safety functions to support INDs, NDAs, and publication plans.

Qualifications

• MD/DO required; residency completed preferred.
• 0–3 years pharma drug development experience.
• Experience in hematologic malignancies desirable.
• Strong leadership and cross-functional collaboration.

Responsibilities

• Design and implement clinical protocols aligned with product plan, with emphasis on hematologic malignancies.
• Provide clinical input to protocols, regulatory documents, and site interactions.
• Lead clinical study teams and monitor study integrity and safety data.
• Present at scientific and regulatory meetings globally.
• Build relationships with investigators, KOLs, and partners.
• Contribute to INDs, NDAs, and related regulatory submissions.
• Collaborate with Drug Safety to assess safety profiles.
• Support translational strategies with Discovery teams.

Skills

Hematological malignancies

Clinical trial design

Regulatory/compliance

Leadership & cross-functional

Scientific communication

Education

MD/DO or non-US equivalent

Residency completed

Subspecialty fellowship desirable

Experience in hematologic malignancies

Job description

Sumitomo Pharma Co., Ltd. is seeking an Associate Medical Director, Clinical Development – Oncology to lead the design, execution, and management of oncology studies. You will foster investigator relationships and guide cross‑functional teams in safety and efficacy assessments across global programs.

The role emphasizes hematologic malignancies and collaboration with regulatory, medical affairs, and safety functions to support INDs, NDAs, and publication plans.